| [1] |
Zhu AX, Macarulla T, Javle MM, et al. Final overall survival efficacy results of ivosidenib for patients with advanced cholangiocarcinoma with IDH1 mutation: the phase 3 randomized clinical ClarIDHy trial[J]. JAMA Oncol, 2021, 7(11): 1669-1677.
|
| [2] |
王宏博，杨业发，葛乃建. 肝外胆管癌的介入治疗现状与展望[J]. 中国癌症杂志, 2022, 32(2): 118-124.
|
| [3] |
Lowery MA, Bradley M, Chou JF, et al. Binimetinib plus gemcitabine and cisplatin phaseⅠ/Ⅱ trial in patients with advanced biliary cancers[J]. Clin Cancer Res, 2019, 25(3): 937-945.
|
| [4] |
中国研究型医院学会消化道肿瘤专业委员会，中国医师协会外科医师分会多学科综合治疗专业委员会. 肝脏及胆道恶性肿瘤多学科综合治疗协作组诊疗模式专家共识[J]. 中国实用外科杂志, 2017, 37(1): 32-34.
|
| [5] |
中国抗癌协会. 远端胆管癌规范化诊治专家共识（2017）[J]. 中华肝胆外科杂志, 2018, 24(1): 1-8.
|
| [6] |
Burke EC, Jarnagin WR, Hochwald SN, et al. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system[J]. Ann Surg, 1998, 228(3): 385-394.
|
| [7] |
Ruzzenente A, Bagante F, Olthof PB, et al. Surgery for Bismuth-Corlette type 4 perihilar cholangiocarcinoma: results from a Western multicenter collaborative group[J]. Ann Surg Oncol, 2021, 28(12): 7719-7729.
|
| [8] |
中华医学会数字医学分会，中国研究型医院学会数字智能化外科专业委员会，中华医学会外科学分会胆道外科学组, 等. 肝门部胆管癌三维可视化精准诊治中国专家共识（2019版）[J]. 中国实用外科杂志, 2020, 40(3): 260-266.
|
| [9] |
黄伟，刘会春，王远鹏, 等. 胆管癌患者腔内综合治疗与姑息性手术疗效比较[J]. 中华肝胆外科杂志, 2017, 23(6): 389-394.
|
| [10] |
Labib P, Davidson BR, Sharma RA, et al. Locoregional therapies in cholangiocarcinoma[J]. Hepat Oncol, 2017, 4(4): 99-109.
|
| [11] |
王勇，刘会春，李宗狂, 等. 经皮胆道支架联合125I粒子腔内植入治疗恶性梗阻性黄疸的初步研究[J]. 中华放射学杂志, 2014, 48(5): 403-407.
|
| [12] |
Pang Q, Zhou L, Hu XS, et al. Biliary stenting alone versus biliary stenting combined with 125I particles intracavitary irradiation for the treatment of advanced cholangiocarcinoma[J]. Sci Rep, 2019, 9(1): 11348.
|
| [13] |
方驰华，田捷，张鹏, 等. 数字医学技术在肝胆胰外科的应用：20年历史回顾与未来展望[J]. 中华外科杂志, 2021, 59(10): 807-811.
|
| [14] |
Miura S, Kanno A, Masamune A, et al. Risk factors for recurrent biliary obstruction following placement of self-expandable metallic stents in patients with malignant perihilar biliary stricture[J]. Endoscopy, 2016, 48(6): 536-545.
|
| [15] |
金浩，刘会春，李宗狂, 等. 超细胆道镜在经皮经肝途径胆管肿瘤活检中的应用[J]. 中国微创外科杂志, 2017, 17(8): 698-700.
|
| [16] |
Inchingolo R, Acquafredda F, Ferraro V, et al. Non-surgical treatment of hilar cholangiocarcinoma[J]. World J Gastrointest Oncol, 2021, 13(11): 1696-1708.
|
| [17] |
Yang J, Wang J, Zhou H, et al. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: A randomized trial[J]. Endoscopy, 2018, 50(8): 751-760.
|
| [18] |
胡惠，王宗鼎，李可洲, 等. 氟尿嘧啶联合丝裂霉素通过改变自噬作用抑制胆管癌细胞QBC939衰老并促进凋亡[J]. 第三军医大学学报, 2013, 35(18): 1915-1920.
|
| [19] |
Sriraksa R, Limpaiboon T. TRAIL in combination with subtoxic 5-FU effectively inhibit cell proliferation and induce apoptosis in cholangiocarcinoma cells[J]. Asian Pac J Cancer Prev, 2015, 16(16): 6991-6996.
|
| [20] |
Hsu C, Shen YC, Yang CH, et al. Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract[J]. Br J Cancer, 2004, 90(9): 1715-1719.
|
| [21] |
陈晓明，陆骊工，李勇, 等. 完全型恶性阻塞性黄疸胆管再通的方法探讨[J]. 临床放射学杂志, 2006, 25(11): 1051-1054.
|
| [22] |
胡小四，庞青，刘会春, 等. 胆道支架植入联合胆管腔内灌注化疗在晚期肝外胆管癌中的应用[J]. 蚌埠医学院学报, 2019, 44(9): 1186-1190.
|
| [23] |
Zhu HD, Guo JH, Huang M, et al. Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: A multicentre trial[J]. J Hepatol, 2018, 68(5): 970-977.
|
| [24] |
张晓，王亚东，蔡建平, 等. 伞状管外引流并125I粒子内放射治疗晚期肝门部胆管癌[J]. 实用医学杂志, 2015, 31(3): 449-451.
|
| [25] |
胡小四，庞青，刘会春, 等. 经皮胆道支架联合导管载入式125I粒子治疗局部进展期肝外胆管癌的疗效评价与预后因素分析[J]. 介入放射学杂志, 2019, 4(28): 369-375.
|
| [26] |
梅治永，庞青，王勇, 等. 支架联合125I粒子腔内照射与姑息性手术治疗晚期肝外胆管癌的对比研究[J/CD]. 中华普通外科学文献（电子版）, 2021, 15(6): 412-417.
|